The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged
- PMID: 19273747
- PMCID: PMC2717716
- DOI: 10.1001/archneurol.2009.27
The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged
Abstract
In recent years a rapidly increasing number of studies has focused on the relationship between dementia and metabolic disorders such as diabetes, obesity, hypertension, and dyslipidemia. Etiological heterogeneity and comorbidity pose challenges for determining relationships among metabolic disorders. The independent and interactive effects of brain vascular injury and classic pathological agents such as beta-amyloid have also proved difficult to distinguish in human patients, blurring the lines between Alzheimer disease and vascular dementia. This review highlights recent work aimed at identifying convergent mechanisms such as insulin resistance that may underlie comorbid metabolic disorders and thereby increase dementia risk. Identification of such convergent factors will not only provide important insight into the causes and interdependencies of late-life dementias but will also inspire novel strategies for treating and preventing these disorders.
Figures
Similar articles
-
Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia.Ageing Res Rev. 2024 Apr;96:102250. doi: 10.1016/j.arr.2024.102250. Epub 2024 Feb 26. Ageing Res Rev. 2024. PMID: 38417711 Review.
-
The role of insulin in the vascular contributions to age-related dementia.Biochim Biophys Acta. 2016 May;1862(5):983-91. doi: 10.1016/j.bbadis.2015.11.013. Epub 2015 Dec 2. Biochim Biophys Acta. 2016. PMID: 26657615 Review.
-
Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia.Neuropharmacology. 2018 Jul 15;137:164-177. doi: 10.1016/j.neuropharm.2018.04.021. Epub 2018 May 5. Neuropharmacology. 2018. PMID: 29738850
-
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2. Ageing Res Rev. 2010. PMID: 20444434 Review.
-
Models and mechanisms of vascular dementia.Exp Neurol. 2015 Oct;272:97-108. doi: 10.1016/j.expneurol.2015.05.006. Epub 2015 May 15. Exp Neurol. 2015. PMID: 25987538 Free PMC article. Review.
Cited by
-
Investigating CR1 as an indicated Gene for mild cognitive impairment in type 2 diabetes mellitus.Diabetol Metab Syndr. 2024 Aug 24;16(1):206. doi: 10.1186/s13098-024-01449-y. Diabetol Metab Syndr. 2024. PMID: 39182129 Free PMC article.
-
Can physical activity counteract the negative effects of sedentary behavior on the physical and mental health of children and adolescents? A narrative review.Front Public Health. 2024 Aug 2;12:1412389. doi: 10.3389/fpubh.2024.1412389. eCollection 2024. Front Public Health. 2024. PMID: 39157520 Free PMC article. Review.
-
Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.JAMA. 2024 Jul 28:e246619. doi: 10.1001/jama.2024.6619. Online ahead of print. JAMA. 2024. PMID: 39068543
-
Does Physical Exercise Modify the Pathophysiology of Alzheimer's Disease in Older Persons?JAR Life. 2024 May 22;13:77-81. doi: 10.14283/jarlife.2024.11. eCollection 2024. JAR Life. 2024. PMID: 38803456 Free PMC article. Review.
-
The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature.Mol Biol Rep. 2024 Apr 5;51(1):493. doi: 10.1007/s11033-024-09457-x. Mol Biol Rep. 2024. PMID: 38580818 Review.
References
-
- DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214–223. - PubMed
-
- Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15–26. - PubMed
-
- Reaven G. Why a cluster is truly a cluster: insulin resistance and cardiovascular disease. Clin Chem. 2008 May;54(5):785–787. - PubMed
-
- Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 2004 Mar;3(3):169–178. - PubMed